Literature DB >> 12069190

CXC chemokine expression after stimulation with interferon-gamma in primary rat hepatocytes in culture.

Xiaodan Ren1, Audra Kennedy, Lisa Marie Colletti.   

Abstract

Monokine-induced by gamma interferon (MIG) and gamma-interferon-inducible protein (IP-10) are members of the CXC chemokine family that have been shown to be induced by interferon-gamma (IFNy) in some cell types. The purpose of this investigation was to determine whether IFNgamma influences CXC chemokine production, particularly MIG and IP-10, in primary rat hepatocytes in culture. Previous experiments in our laboratory have demonstrated that pharmacologic doses of IFNgamma in an in vivo model of hepatic ischemia/reperfusion-induced liver injury resulted in increased hepatic levels of IP-10 and MIG and decreased hepatic levels of macrophage inflammatory protein-2, Kupffer cells, and epithelial neutrophil-activating protein, with a concomitant decrease in neutrophil-mediated hepatic injury. In the current investigation, MIG and IP-10 mRNA and protein were up-regulated in primary rat hepatocytes in vitro in response to IFNgamma. Although MIG and IP-10 mRNA were both somewhat increased at early time points, larger increases in these chemokines were seen at later time points, specifically at 24, 48, and 72 h of incubation as compared to controls. Levels of Kupffer cells and macrophage inflammatory protein-2 mRNA after IFNgamma were negligible and similar to those seen in controls. These findings were confirmed by enzyme-linked immunosorbent assay analysis. These studies demonstrate that IFNgamma in vitro up-regulates the production of MIG and IP-10, at both the mRNA and protein levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12069190     DOI: 10.1097/00024382-200206000-00013

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  10 in total

Review 1.  Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies?

Authors:  Alex Boye; Yu-Hong Zou; Yan Yang
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Preservation of hepatic blood flow by direct peritoneal resuscitation improves survival and prevents hepatic inflammation following hemorrhagic shock.

Authors:  Ryan T Hurt; Paul J Matheson; Jason W Smith; El Rasheid Zakaria; Saad P Shaheen; Craig J McClain; R Neal Garrison
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-20       Impact factor: 4.052

3.  TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein.

Authors:  Deborah L Clarke; Rachel L Clifford; Sarawut Jindarat; David Proud; Linhua Pang; Maria Belvisi; Alan J Knox
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

4.  Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.

Authors:  Kenneth E Sherman; Enass A Abdel-Hameed; Richard L Ehman; Susan D Rouster; Adriana Campa; Sabrina Sales Martinez; Yongjun Huang; Gustavo G Zarini; Jacqueline Hernandez; Colby Teeman; Javier Tamargo; Qingyun Liu; Raul Mandler; Marianna K Baum
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

5.  CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

Authors:  Edith Hintermann; Monika Bayer; Josef M Pfeilschifter; Andrew D Luster; Urs Christen
Journal:  J Autoimmun       Date:  2010-10-06       Impact factor: 7.094

6.  Limited role for CXC chemokines in the pathogenesis of alpha-naphthylisothiocyanate-induced liver injury.

Authors:  Junquan Xu; Gene Lee; Haimei Wang; John M Vierling; Jacquelyn J Maher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-05-06       Impact factor: 4.052

7.  Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.

Authors:  Hermann E Wasmuth; Frank Lammert; Mirko Moreno Zaldivar; Ralf Weiskirchen; Claus Hellerbrand; David Scholten; Marie-Luise Berres; Henning Zimmermann; Konrad L Streetz; Frank Tacke; Sonja Hillebrandt; Petra Schmitz; Hildegard Keppeler; Thomas Berg; Edgar Dahl; Nikolaus Gassler; Scott L Friedman; Christian Trautwein
Journal:  Gastroenterology       Date:  2009-04-01       Impact factor: 22.682

8.  Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium.

Authors:  Pallavi B Limaye; William C Bowen; Anne V Orr; Jianhua Luo; George C Tseng; George K Michalopoulos
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

9.  Spred2 controls the severity of Concanavalin A-induced liver damage by limiting interferon-gamma production by CD4+ and CD8+ T cells.

Authors:  Cuiming Sun; Masayoshi Fujisawa; Toshiaki Ohara; Qiuying Liu; Chen Cao; Xu Yang; Teizo Yoshimura; Steven L Kunkel; Akihiro Matsukawa
Journal:  J Adv Res       Date:  2021-04-20       Impact factor: 10.479

10.  Curative Effects of Thiacremonone against Acetaminophen-Induced Acute Hepatic Failure via Inhibition of Proinflammatory Cytokines Production and Infiltration of Cytotoxic Immune Cells and Kupffer Cells.

Authors:  Yu Ri Kim; Nam Jin Lee; Jung Ok Ban; Hwan Soo Yoo; Yong Moon Lee; Yeo Pyo Yoon; So Young Eum; Heon Sang Jeong; Do-Young Yoon; Sang Bae Han; Jin Tae Hong
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-11       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.